Oncofertility is an interdisciplinary field that focuses on preserving the reproductive potential of individuals diagnosed with cancer. As cancer treatments continue to improve survival outcomes, maintaining quality of life after therapy has become an important priority in oncology care. Many cancer treatments such as chemotherapy, radiation therapy, and certain surgical procedures can impair reproductive function, making fertility preservation an essential consideration for patients of reproductive age. Advances in reproductive science and oncology are frequently presented at global scientific gatherings such as a Cancer Conference, where experts explore innovative strategies to protect fertility during cancer treatment and improve long-term survivorship outcomes related to fertility preservation in cancer patients.

The concept of oncofertility emerged from the recognition that cancer therapies, while lifesaving, can significantly affect reproductive organs and hormonal balance. Treatments that target rapidly dividing cells may damage ovarian follicles, sperm-producing cells, or reproductive tissues. This can lead to temporary or permanent infertility depending on the patient’s age, treatment intensity, and type of therapy administered. Oncofertility research therefore aims to develop methods that allow patients to pursue effective cancer treatment while preserving their future ability to conceive biological children.

Modern fertility preservation strategies include several medical and laboratory techniques designed to safeguard reproductive potential before cancer therapy begins. For women, these options may involve egg freezing, embryo cryopreservation, ovarian tissue preservation, or hormonal treatments that help protect ovarian function during therapy. For men, sperm banking remains one of the most common and effective fertility preservation approaches. Researchers are also exploring experimental techniques such as in vitro maturation of reproductive cells and tissue transplantation, which may expand options for patients who cannot delay cancer treatment.

In addition to clinical techniques, oncofertility also addresses the psychological, ethical, and counseling aspects associated with fertility decisions in cancer care. Patients often face complex choices regarding treatment timing, reproductive planning, and long-term health considerations. Multidisciplinary care teams including oncologists, reproductive specialists, genetic counselors, and mental health professionals collaborate to guide patients through these decisions. Continued research in this field aims to improve fertility preservation technologies, enhance patient counseling resources, and ensure that reproductive health remains an integral component of comprehensive cancer care.